Tetratherix Limited (ASX:TTX)

Australia flag Australia · Delayed Price · Currency is AUD
3.945
-0.055 (-1.38%)
Mar 11, 2026, 3:54 PM AEST
Market Cap200.27M
Revenue (ttm)2.00M +157.2%
Net Income-11.97M
EPS-0.31
Shares Out50.77M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,510
Average Volume5,131
Open4.050
Previous Close4.000
Day's Range3.840 - 4.050
52-Week Range2.880 - 5.600
Betan/a
RSI56.54
Earnings DateMay 22, 2026

About Tetratherix

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 15
Stock Exchange Australian Securities Exchange
Ticker Symbol TTX
Full Company Profile

Financial Performance

In fiscal year 2025, Tetratherix's revenue was 1.05 million, an increase of 21.88% compared to the previous year's 863,651. Losses were -9.43 million, 269.1% more than in 2024.

Financial Statements